Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma.
D000403:Airway Resistance / Q000187:drug effects; D000485:Allergens / Q000276:immunology; D000818:Animals; D001249:Asthma / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control*; D016535:Bronchial Hyperreactivity / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D002460:Cell Line; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D004804:Eosinophils / Q000187:drug effects / Q000473:pathology; D005260:Female; D007155:Immunologic Factors / Q000737:chemistry / Q000494:pharmacology*; D007249:Inflammation / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control; D051379:Mice; D008807:Mice, Inbred BALB C; D016328:NF-kappa B / Q000378:metabolism; D009841:Oligonucleotides / Q000737:chemistry / Q000494:pharmacology*
D000485:Allergens; D016207:Cytokines; D007155:Immunologic Factors; D016328:NF-kappa B; D009841:Oligonucleotides